Evidence map›Paper›PMID 32722559›Full record

ReviewInternational journal of molecular sciences2020

The Functional Roles and Applications of Immunoglobulins in Neurodegenerative Disease.

Kyu-Young Sim, Kyeong Chan Im, Sung-Gyoo Park

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.0field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Kyu-Young SimSchool of Life Sciences, Gwangju Institute of Science and Technology (GIST), Gwangju 61005, Korea.
Kyeong Chan ImSchool of Life Sciences, Gwangju Institute of Science and Technology (GIST), Gwangju 61005, Korea.
Sung-Gyoo ParkSchool of Life Sciences, Gwangju Institute of Science and Technology (GIST), Gwangju 61005, Korea.ORCID 0000-0003-3702-5765
Gwangju Institute of Science and Technology · KR

Funding

National Research Foundation of Korea 2016M3C7A1905475National Research Foundation of Korea 2017R1E1A1A01074299Research of Korea Centers for Disease Control and Prevention 2020-ER6902-00
6 · The paper itself

Abstract

Natural autoantibodies, immunoglobulins (Igs) that target self-proteins, are common in the plasma of healthy individuals; some of the autoantibodies play pathogenic roles in systemic or tissue-specific autoimmune diseases, such as rheumatoid arthritis and systemic lupus erythematosus. Recently, the field of autoantibody-associated diseases has expanded to encompass neurodegenerative diseases such as Alzheimer's disease (AD) and Parkinson's disease (PD), with related studies examining the functions of Igs in the central nervous system (CNS). Recent evidence suggests that Igs have various effects in the CNS; these effects are associated with the prevention of neurodegeneration, as well as induction. Here, we summarize the functional roles of Igs with respect to neurodegenerative disease (AD and PD), focusing on the target antigens and effector cell types. In addition, we review the current knowledge about the roles of these antibodies as diagnostic markers and immunotherapies.

Indexed as

Alzheimer DiseaseAutoantibodiesAutoantigensAutoimmune DiseasesBrainHumansParkinson DiseaseAutoantibodiesAutoantigensAlzheimer’s diseasediagnostic markerimmunoglobulinimmunotherapyParkinson’s disease

Identifiers

PMID32722559
PMCPMC7432158
OpenAlexW3044925194

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.